Skip to main content

Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning.

Publication ,  Journal Article
Boelens, JJ; Aldenhoven, M; Purtill, D; Ruggeri, A; Defor, T; Wynn, R; Wraith, E; Cavazzana-Calvo, M; Rovelli, A; Fischer, A; Tolar, J ...
Published in: Blood
May 9, 2013

We report transplantation outcomes of 258 children with Hurler syndrome (HS) after a myeloablative conditioning regimen from 1995 to 2007. Median age at transplant was 16.7 months and median follow-up was 57 months. The cumulative incidence of neutrophil recovery at day 60 was 91%, acute graft-versus-host disease (GVHD) (grade II-IV) at day 100 was 25%, and chronic GVHD and 5 years was 16%. Overall survival and event-free survival (EFS) at 5 years were 74% and 63%, respectively. EFS after HLA-matched sibling donor (MSD) and 6/6 matched unrelated cord blood (CB) donor were similar at 81%, 66% after 10/10 HLA-matched unrelated donor (UD), and 68% after 5/6 matched CB donor. EFS was lower after transplantation in 4/6 matched unrelated CB (UCB) (57%; P = .031) and HLA-mismatched UD (41%; P = .007). Full-donor chimerism (P = .039) and normal enzyme levels (P = .007) were higher after CB transplantation (92% and 98%, respectively) compared with the other grafts sources (69% and 59%, respectively). In conclusion, results of allogeneic transplantation for HS are encouraging, with similar EFS rates after MSD, 6/6 matched UCB, 5/6 UCB, and 10/10 matched UD. The use of mismatched UD and 4/6 matched UCB was associated with lower EFS.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Blood

DOI

EISSN

1528-0020

Publication Date

May 9, 2013

Volume

121

Issue

19

Start / End Page

3981 / 3987

Location

United States

Related Subject Headings

  • Young Adult
  • Treatment Outcome
  • Transplantation Conditioning
  • Tissue and Organ Procurement
  • Tissue Donors
  • Retrospective Studies
  • Myeloablative Agonists
  • Mucopolysaccharidosis I
  • Male
  • Infant
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Boelens, J. J., Aldenhoven, M., Purtill, D., Ruggeri, A., Defor, T., Wynn, R., … Centre for International Blood and Marrow Research, . (2013). Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. Blood, 121(19), 3981–3987. https://doi.org/10.1182/blood-2012-09-455238
Boelens, Jaap Jan, Mieke Aldenhoven, Duncan Purtill, Annalisa Ruggeri, Todd Defor, Robert Wynn, Ed Wraith, et al. “Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning.Blood 121, no. 19 (May 9, 2013): 3981–87. https://doi.org/10.1182/blood-2012-09-455238.
Boelens JJ, Aldenhoven M, Purtill D, Ruggeri A, Defor T, Wynn R, et al. Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. Blood. 2013 May 9;121(19):3981–7.
Boelens, Jaap Jan, et al. “Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning.Blood, vol. 121, no. 19, May 2013, pp. 3981–87. Pubmed, doi:10.1182/blood-2012-09-455238.
Boelens JJ, Aldenhoven M, Purtill D, Ruggeri A, Defor T, Wynn R, Wraith E, Cavazzana-Calvo M, Rovelli A, Fischer A, Tolar J, Prasad VK, Escolar M, Gluckman E, O’Meara A, Orchard PJ, Veys P, Eapen M, Kurtzberg J, Rocha V, Eurocord, Inborn Errors Working Party of European Blood and Marrow Transplant group, Duke University Blood and Marrow Transplantation Program, Centre for International Blood and Marrow Research. Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. Blood. 2013 May 9;121(19):3981–3987.

Published In

Blood

DOI

EISSN

1528-0020

Publication Date

May 9, 2013

Volume

121

Issue

19

Start / End Page

3981 / 3987

Location

United States

Related Subject Headings

  • Young Adult
  • Treatment Outcome
  • Transplantation Conditioning
  • Tissue and Organ Procurement
  • Tissue Donors
  • Retrospective Studies
  • Myeloablative Agonists
  • Mucopolysaccharidosis I
  • Male
  • Infant